Kotak upgrades Biocon after recent share-price correction
In short
Kotak Institutional Equities upgraded Biocon after its share price fell recently. The brokerage said the stock now looks better on risk and reward, even though execution was weak in the first half of FY27.
What the reporting says
Kotak Institutional Equities upgraded Biocon after a recent correction in the stock improved the risk-reward profile. The brokerage also said execution was subdued in the first half of FY27.
Why it matters
Kotak Institutional Equities upgraded Biocon after a recent correction in its share price improved the risk-reward profile. The note also flagged subdued execution in the first half of FY27, which suggests the brokerage still sees operational issues.